Want to see JP:3695 full AI Analyst Report?

GMO Research & AI,Inc. (3695) Price & Analysis

0 Followers

3695 Stock Chart & Stats

¥1981.00

-¥42.00(-1.74%)

At close: Jan 08 4:00 PM EST

¥1981.00

-¥42.00(-1.74%)

Day’s Range― - ―

52-Week Range¥1,413.00 - ¥2,775.00

Previous CloseN/A

Volume3.20K

Average Volume (3M)4.97K

Market Cap

¥6.36B

Enterprise Value¥5.74B

Total Cash (Recent Filing)¥5.56B

Total Debt (Recent Filing)¥622.07M

Price to Earnings (P/E)15.2

Beta0.47

Next Earnings

Aug 13, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield4.12%

Share Statistics

EPS (TTM)94.99

Shares Outstanding4,446,357

10 Day Avg. Volume4,400

30 Day Avg. Volume4,966

Financial Highlights & Ratios

PEG Ratio-0.81

Price to Book (P/B)3.27

Price to Sales (P/S)1.17

P/FCF Ratio8.06

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue Recovery And Gross Margin ExpansionA meaningful 2025 revenue rebound combined with a ~6ppt gross margin uplift indicates improving demand and/or better pricing and cost control. Those dynamics strengthen durable top-line momentum and core profitability potential, supporting sustainable operating cash generation over the medium term.

Strong Free Cash Flow GenerationSubstantial operating and free cash flow in 2025, with high conversion of reported earnings to cash, gives the company durable internal funding for capex, growth initiatives, or debt service. Reliable cash generation reduces reliance on external financing and supports execution of strategic plans.

Historically Healthy Balance Sheet And Equity BaseA strong equity base and a history of minimal leverage provide a structural financial buffer against shocks and fund strategic investments. Even with a recent uptick in debt, the balance sheet's prior conservatism and expanded assets support long-term resilience and optionality.

Bears Say

Net Margin CompressionSteady deterioration in net margin over recent years signals weakening bottom-line conversion despite revenue gains. Persistent margin compression can erode return on incremental sales, constrain free cash flow under stress, and reduce capacity to reinvest or buffer against cyclical downturns.

Step-up In Leverage In 2025The shift from near-zero leverage to material debt is a structural change that raises fixed obligations and refinancing risk. While still moderate, higher leverage tightens financial flexibility, increases sensitivity to cash flow volatility, and raises execution risk if earnings or cash flows soften.

Historic Cash Flow VolatilityPast swings in free cash flow, including a sharp 2022 drop, indicate earnings and cash conversion are not yet consistently stable. That volatility undermines predictability for debt repayment, dividends, and reinvestment, making sustained deleveraging and growth planning more challenging.

GMO Research & AI,Inc. News

Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!

Earnings reports, economic data, deals, and more lead the biggest stock market stories for Wednesday! ...

12M ago

CRM

IBM

3695 FAQ

What was GMO Research & AI,Inc.’s price range in the past 12 months?

GMO Research & AI,Inc. lowest stock price was ¥1413.00 and its highest was ¥2775.00 in the past 12 months.

What is GMO Research & AI,Inc.’s market cap?

GMO Research & AI,Inc.’s market cap is ¥6.36B.

When is GMO Research & AI,Inc.’s upcoming earnings report date?

GMO Research & AI,Inc.’s upcoming earnings report date is Aug 13, 2026 which is in 11 days.

How were GMO Research & AI,Inc.’s earnings last quarter?

GMO Research & AI,Inc. released its earnings results on May 14, 2026. The company reported ¥43.8 earnings per share for the quarter, beating the consensus estimate of N/A by ¥43.8.

Is GMO Research & AI,Inc. overvalued?

According to Wall Street analysts GMO Research & AI,Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does GMO Research & AI,Inc. pay dividends?

GMO Research & AI,Inc. pays a Annually dividend of ¥64.21 which represents an annual dividend yield of 4.12%. See more information on GMO Research & AI,Inc. dividends here

What is GMO Research & AI,Inc.’s EPS estimate?

GMO Research & AI,Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does GMO Research & AI,Inc. have?

GMO Research & AI,Inc. has 4,446,357 shares outstanding.

What happened to GMO Research & AI,Inc.’s price movement after its last earnings report?

GMO Research & AI,Inc. reported an EPS of ¥43.8 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.412%.

Which hedge fund is a major shareholder of GMO Research & AI,Inc.?

Currently, no hedge funds are holding shares in JP:3695

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

GMO Research & AI,Inc.

Established in 2002 and headquartered in Tokyo, Japan, GMO Research & AI, Inc. delivers an audience engagement platform to a global and domestic Japanese clientele. Central to its offering is the Asia Cloud Panel, an extensive online network comprising various survey panels across numerous countries. Beyond this core platform, the company excels in providing rapid, customized survey services, alongside agile and automated solutions for managing data collection. The firm, a subsidiary of GMO internet group, Inc., previously operated under the name GMO Research, Inc. until its renaming to GMO Research & AI, Inc. in May 2024.